Private Medical Practice Acquisition: Financing and Planning for Rheumatology Clinics in 2026

What Is Private Medical Practice Acquisition?

Private medical practice acquisition is the purchase of an existing healthcare clinic or service line by a physician or healthcare entrepreneur, typically financed through a combination of personal capital, business loans, and specialized medical practice financing. The buyer assumes existing patient relationships, staff, equipment, and reputation—essentially purchasing an established revenue stream and operational infrastructure rather than starting from zero.

For rheumatologists and other specialists, practice acquisition offers a faster path to ownership than building a startup clinic. Instead of spending years establishing patient volume, credibility, and operational systems, you inherit existing biologic therapy infrastructure, established referral networks, and a patient census. The trade-off: you pay a premium (typically 0.5 to 1.5 times annual revenue) for that head start, and you must finance the acquisition through business loans designed specifically for healthcare providers.

Why Rheumatologists Acquire Practices Instead of Starting New

Rheumatology is a capital-intensive specialty. Patients with rheumatoid arthritis, lupus, and other autoimmune diseases require ongoing infusion centers, imaging equipment, lab processing, and often co-management with specialists. A startup rheumatology practice faces months—sometimes years—of negative cash flow while building patient volume. Acquired practices, by contrast, generate immediate revenue and patient relationships.

Three concrete advantages drive acquisition over startup:

1. Immediate patient census: A mature practice may have 300–500 active rheumatology patients. You inherit their recurring revenue and referral patterns, eliminating the slow ramp-up of a new practice.

2. Operational infrastructure: The practice already has staff, scheduling systems, EHR implementation, payer contracting, and biologic therapy workflows. You don't need to build these from scratch.

3. Proven financials: Unlike a startup projection, you can audit real revenue, expense, and profitability data for the past 3–5 years. Lenders feel more confident lending on proven cash flow.

How to Qualify for Rheumatology Practice Acquisition Financing

Step 1: Verify Your Medical License and Credentials

Lenders require current, unrestricted medical licensure in the state where the practice operates. They also verify board certification status (board-certified rheumatologists receive better terms than non-certified physicians). Some lenders require malpractice insurance history. This step usually takes 1–2 weeks.

Step 2: Assemble Personal Financial Documentation

You'll need 2 years of personal and business tax returns, personal balance sheet, proof of liquid assets, and professional references. Personal credit score is typically weighted at 60–70% of the approval decision for physician borrowers. Lenders use credit score, length of credit history, payment timeliness, and utilization ratio to assess default risk.

Step 3: Conduct Due Diligence on the Target Practice

Before approaching a lender, you must validate that the practice is worth financing. This means hiring an accountant to audit 3–5 years of financials, verifying patient census and payer mix, confirming lease terms and equipment status, and reviewing staff contracts and compensation. Red flags include declining patient volume, high staff turnover, major payer terminations, or undisclosed liabilities.

Step 4: Develop a Business Plan and Acquisition Model

The lender will require a written plan showing how you'll integrate the practice, retain patients, manage cash flow, and service the loan. This should include a 12-month pro forma income statement, cash flow projections, and debt service coverage calculation. Most lenders want to see debt service coverage ratio (annual cash flow ÷ annual debt payment) of at least 1.25–1.5x for approval.

Step 5: Select Financing Structure and Apply

With your broker or directly to lenders, you'll choose between SBA 7(a) loans (longer terms, lower down payment, slower approval), conventional bank financing (faster, higher down payment), or a hybrid (SBA for practice goodwill, conventional for equipment and working capital). Submit the loan application with all supporting documentation and the practice purchase agreement (usually non-binding until financing is confirmed).

Loan Types: SBA vs. Conventional vs. Specialty Medical Lenders

SBA 7(a) Loans for Medical Practice Acquisition

The Small Business Administration's 7(a) loan program is the most popular financing path for physician practice acquisition. Here's why:

Terms: Up to 10 years for practice goodwill and equipment; up to 25 years for real estate. Interest rates typically float 1.5–2.5% above prime (so 7.5–9.5% in a 6% prime environment). Down payment as low as 10% for experienced buyers.

Advantages: Long repayment period reduces monthly payment burden, lower down payment than conventional loans, and the SBA guarantee (85–90% of the loan amount) makes lenders more willing to approve physician borrowers with limited credit or net worth.

Disadvantages: Slower approval timeline (60–90 days typical), more restrictive use-of-funds rules (you can't use SBA proceeds for working capital beyond a small percentage), and compliance requirements (SBA-backed loans require annual financial reporting and restrict equity transfers without lender consent).

Conventional Bank Loans

Regional and national banks offer medical practice loans without SBA backing. These are faster but require stronger personal balance sheet.

Terms: 5–7 year amortization, interest rates typically 0.5–1% higher than SBA, down payment 20–30%, approval in 30–45 days.

Advantages: Faster closing, more flexibility on use of proceeds (e.g., working capital, equipment, practice improvements), and no annual SBA reporting requirement.

Disadvantages: Higher down payment, shorter repayment term (higher monthly payment), and tighter credit score requirements (usually 720+ personal credit score).

Specialty Medical Practice Lenders

Companies like Capstone Practice Solutions, Elevate Financial, and others specialize in healthcare provider loans. They understand medical practice valuation, payer contracts, and rheumatology operations.

Terms: 5–10 years, rates 6–10% depending on credit and practice strength, down payment 15–25%, approval in 45–60 days.

Advantages: Faster than SBA due to streamlined underwriting, underwriters understand medical practice cash flow (e.g., biologic therapy revenue, infusion center economics), and willing to work with physicians early in independent practice ownership.

Disadvantages: Smaller maximum loan amounts (typically $500K–$3M vs. SBA up to $5M+), less price transparency (rates vary significantly by lender), and fewer regulatory protections than SBA or bank loans.

Structuring the Acquisition: Asset Purchase vs. Share Purchase

You can structure the deal as either an asset purchase (you buy the patient list, equipment, lease, and goodwill) or a share purchase (you buy the practice entity itself, inheriting all assets and liabilities). Most physician acquisitions use asset purchase because it's cleaner: you assume only what you negotiate, and the seller retains any hidden liabilities. The downside is that you don't step into the seller's payer contracts or tax history, sometimes requiring renegotiation with insurance companies.

Asset purchase for acquisition financing:

• Lender sees the purchase price split into tangible assets (equipment, lease assignment, patient list) and intangible assets (goodwill).
• Equipment is typically valued at fair market value (often 40–60% of purchase price for rheumatology).
• Goodwill (practice reputation, patient relationships) makes up the remainder and is financed as practice goodwill under SBA or medical practice loans.
• Allows tax deductions for equipment depreciation and goodwill amortization (15-year straight-line depreciation under IRS Section 197).

Share purchase for acquisition financing:

• Less common but sometimes used when the seller wants a cleaner exit or the practice has valuable payer contracts.
• You inherit all liabilities, so due diligence must be exhaustive.
• Usually requires personal guarantee from buyer and key-person insurance on critical staff.
• May trigger change-of-control provisions in existing staff or payer contracts.

Financial Modeling and Valuation

Rheumatology practices are valued using a multiple of annual revenue or earnings. Typical valuation ranges:

• EBITDA multiple: 2.0–3.5x annual earnings (for high-profitability practices).
• Revenue multiple: 0.5–1.5x annual revenue (for practices with lower margins or higher overhead).
• Discounted cash flow: Net present value of 5-year projected cash flow, discounted at buyer's required rate of return (usually 10–15% for physician buyers).

Example: A rheumatology practice generating $800K in annual EBITDA might be valued at $2.4M–$2.8M (3x EBITDA mid-range). If you're financing 90% with an SBA 7(a) loan at 8% over 10 years, your monthly debt service is approximately $27,700. To qualify, the practice must generate sufficient cash flow to cover this payment, staff costs, rent, and supplies while maintaining a 1.25+ debt service coverage ratio.

Due Diligence Checklist for Rheumatology Practice Acquisition

Financial Review:

• 3–5 years of tax returns and profit-and-loss statements.
• Accounts receivable aging and bad-debt reserve.
• Payer mix breakdown (Medicare, commercial, Medicaid) and average reimbursement by payer.
• Biologic therapy revenue (often 40–60% of rheumatology revenue) and rebate/co-pay structure.
• Verify no undisclosed debt, liens, or judgments against the practice.

Operational Review:

• Current staffing (rheumatologists, mid-level providers, nurses, support staff) and compensation commitments.
• Patient census (active patients, new patient rate, patient retention).
• Lease terms and renewal options for office and infusion space.
• Equipment inventory, age, and maintenance contracts (imaging, infusion pumps, lab).
• EHR system, licensing, and data transfer logistics.

Legal and Compliance:

• Verify licenses and credentialing for all clinical staff.
• Review malpractice insurance claims history and tail coverage availability.
• Confirm payer contracts remain in force post-acquisition (many require assignment to new owner).
• Check for pending regulatory investigations, compliance violations, or prior fraud allegations.
• Review non-compete and non-solicitation agreements with departing owner.

Market and Referral Analysis:

• Verify referring physician relationships (cardiology, orthopedics, primary care) are intact post-transition.
• Confirm patient volume trends aren't declining due to market saturation or competitive pressure.
• Identify any at-risk payer contracts (e.g., Medicare Advantage plans, narrow networks) that might decline post-acquisition.

Cash Flow and Working Capital Planning for Acquisition

A common pitfall: financing the purchase price but running out of working capital three months into ownership. Rheumatology practices have predictable cash flow but front-load certain expenses.

Typical cash flow timeline post-acquisition:

Months 1–3: Staff orientation, patient communication, payer credentialing. During this period, expect 10–20% patient attrition as some patients leave due to ownership change or seek new providers. Cash flow dips.

Months 4–6: Patient volume stabilizes, new patient referrals rebuild. Biologic therapy revenue remains stable (most patients on established treatment regimens). Cash flow recovers but remains 5–10% below pre-acquisition levels.

Months 7–12: Full patient recovery. You should reach pre-acquisition patient volume and revenue. Some practices see new patient growth due to improved marketing or operational efficiency.

Working capital needs:

• Float for accounts receivable (biologic therapy claims take 30–45 days to pay; medical practices typically need 60–90 days of operating expenses in cash reserves).
• Staff payroll (rheumatology practices have high payroll as % of revenue, often 40–50%).
• Equipment and supplies (imaging film, infusion supplies, lab reagents).
• Transition costs (legal, accounting, IT, staff retraining, marketing).

Recommended working capital reserve: 3–6 months of operating expenses. For a $2.4M acquisition with $1.8M annual operating expenses, you'd want $450K–$900K in cash reserves. This is often financed as a separate line of credit or working capital term loan (often 3–5 year term, not amortized over 10 years like the practice purchase).

Tax Considerations and Deductions for Medical Practice Owners

Practice Goodwill Amortization

Under IRS Section 197, when you buy a medical practice, the portion of the purchase price allocated to goodwill (patient relationships, reputation, referral base) can be amortized over 15 years. This creates a tax deduction even though it's not a cash expense—valuable for reducing taxable income in the early years of ownership.

Example: $2.4M practice purchase with $1M allocated to goodwill. Annual goodwill amortization deduction: $1M ÷ 15 = $66,667/year.

Equipment Depreciation

Medical equipment (imaging machines, infusion pumps, lab equipment, computers) depreciates under MACRS. Most equipment depreciates over 5–7 years, allowing faster write-offs than goodwill.

Interest Deduction on Acquisition Loans

Loan interest (but not principal payments) is deductible as a business expense. In the early years of a 10-year loan, interest payments are higher, so the tax benefit is larger.

Practice-Related Tax Credits

Some states and localities offer small-business tax credits for practice expansion or hiring. Check your state's economic development agency for rheumatology-specific programs (e.g., biologic therapy access expansion grants).

Qualified Business Income (QBI) Deduction

If structured as a C-corporation, the practice may be eligible for the 20% qualified business income deduction under IRC Section 199A (depending on passive income levels and income thresholds).

Note: Tax treatment of practice acquisitions is complex and varies by entity structure (S-corp, LLC, C-corp) and state. Work with a healthcare CPA or tax attorney before closing.

Integration Planning: First 90 Days Post-Acquisition

Once financing closes and you own the practice, the first 90 days determine whether you retain or lose patients and cash flow.

Week 1–2:

• Introduce yourself to all staff and patients via email and in-office signage.
• Confirm no changes to patient care protocols, medication regimens, or appointment scheduling.
• Meet with existing rheumatologists or mid-level providers and establish expectations.
• Verify all payer credentialing is processing and no claims are held up due to ownership change.

Week 3–8:

• Complete payer contract assignments or renegotiations.
• Audit and integrate EHR, if needed.
• Finalize lease and equipment transfers to your name.
• Communicate with top referring physicians to confirm continuity.

Week 9–12:

• Review patient retention metrics and identify at-risk patients.
• Implement any operational improvements (e.g., biologic therapy authorization streamlining, infusion center scheduling).
• Set staff retention incentives or bonuses for successful transition.
• Begin planning for growth: new service lines, additional providers, or satellite locations.

Avoiding Common Acquisition Financing Mistakes

Mistake 1: Underestimating due diligence costs Many buyers finance only the practice purchase but not the $15K–$40K in accounting, legal, and valuation fees. Budget these separately and ensure your working capital reserve covers them.

Mistake 2: Overleveraging Buying at the maximum loan amount (often 90% of practice value) leaves no cushion if patient volume drops post-acquisition. Aim for 70–80% LTV (loan-to-value) if possible to maintain safety margin.

Mistake 3: Ignoring staff turnover risk If the practice has high clinical staff turnover or key providers are considering retirement, patient relationships become fragile. Ask about staff contracts and non-competes before closing.

Mistake 4: Not securing malpractice tail coverage When you buy the practice, you inherit prior claims history. If a patient claim from 2 years ago surfaces post-acquisition and the seller's insurance has expired, you're liable. Negotiate tail insurance as part of the purchase agreement.

Mistake 5: Underestimating integration time Plans to "run the practice on day one" rarely work. Staff, patients, and payers need 60–90 days to adjust. Preserve cash and expect lower revenue during this window.

Bottom Line

Private medical practice acquisition is a viable financing strategy for rheumatologists seeking faster ownership than startup. Structure your deal carefully—use SBA or medical practice loans to spread payments over 10 years, ensure adequate working capital for transition, and conduct thorough due diligence on practice financials and operations. The key is matching the loan term to your expected cash flow and maintaining a 1.25–1.5x debt service coverage ratio. With proper planning, you can own and operate a profitable rheumatology practice within 2–3 years of acquisition.

To explore whether practice acquisition financing is right for your situation, check rates and terms from SBA-approved medical practice lenders.

Disclosures

This content is for educational purposes only and is not financial advice. rheumaevidence1.com may receive compensation from partner lenders, which may influence which products are featured. Rates, terms, and availability vary by lender and applicant qualifications.